TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/25/2024
Back to search
Official data from USPTO
ACCREDO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000077364413Class
35, 41, 42, 44
Filing
77364413
Registration
3667385
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
10/01/2024
Trademark type
Combined
Nice classes
35, 41, 42, 44
Filing date
01/04/2008
Registration date
08/11/2009
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/24/2019
Last transaction
10/01/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/18/2008
First use in commerce
10/18/2008
Drawing code
5
Owner type
03
Owner location
ST. LOUIS, MO, US
Examiner
SHANAHAN, PATRICK
Law office
M70
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of the stylized literal element.
Holders and representatives
Holders
EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC.
Accredo Health Group, Inc.
Representatives
Troy E. Larson
Technical classification
Nice Classes
Class 35Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Retail pharmacy services specializing in the treatment and control of chronic diseases; retail pharmacy services specializing in the control of hemophilia
Class 41
Providing patient educational servicesconducting programs in the field of chronic diseaseproper product-reconstitution and administrationresources appropriate for support of disease management; educational services for product manufacturerspharmaceutical clinicians and biotech companiesclinicianscontract research organizations and insurance providersconducting classesone-on-one sessions and telephonic workshops in the field of clinical education and distributing course materials in connection therewith; educational servicesclassesone on one sessions and telephonic workshops which provide physiciansinsurance companies and patients with specific characteristics associated with disease management products; educational services and resourcesconducting workshops for children to help them to understand hemophilia; educational servicesconducting workshops for children to help them understand hemophilia
Class 42
Providing clinical research in the field of medicine for product manufacturerspharmaceutical and biotech companiescontract research organizations and insurance providersproviding consulting services in support of new drug product launches
Class 44
Nursing care specializing in the treatment and control of chronic diseases; nursing care specializing in the treatment and control of hemophilia; medical servicesadministration of pharmaceutical preparations used in the treatment of chronic diseases and administration of pharmaceutical preparations used in the treatment of hemophilia; administration of pharmaceutical preparations used in the treatment of chronic diseases; providing information concerning medical care and treatment in the field of hemophilia; disease management services; telephone hotline counselingoffering healthcare advice regarding bleeding disorders; services consisting of providing nutritional guidance and consultation to chronically ill patients; medical servicesspecialized pharmaceutical advice for individuals with bleeding disorders
Publications
History of USPTO decisions and trademark events.
40 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/25/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/25/2024
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/24/2019
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/24/2019
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/24/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/20/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/12/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
08/12/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/04/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/04/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/11/2018
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/03/2017
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/05/2015
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/05/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/05/2015
E815
TEAS SECTION 8 & 15 RECEIVED
08/06/2015
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/16/2013
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/16/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
08/11/2009
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
07/06/2009
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/06/2009
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/02/2009
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/02/2009
IUAF
USE AMENDMENT FILED
05/13/2009
EISU
TEAS STATEMENT OF USE RECEIVED
05/13/2009
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
11/18/2008
PUBO
PUBLISHED FOR OPPOSITION
08/26/2008
NPUB
NOTICE OF PUBLICATION
08/06/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/24/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/23/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/22/2008
ALIE
ASSIGNED TO LIE
07/22/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/21/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/21/2008
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/24/2008
GNRT
NON-FINAL ACTION E-MAILED
03/24/2008
CNRT
NON-FINAL ACTION WRITTEN
03/24/2008
DOCK
ASSIGNED TO EXAMINER
03/24/2008
NWAP
NEW APPLICATION ENTERED
01/08/2008
Continuous trademark protection
Get notified about every new filing that threatens ACCREDO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.